Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Biofrontera (BFRI) Invested Capital (2020 - 2025)

Historic Invested Capital for Biofrontera (BFRI) over the last 6 years, with Q3 2025 value amounting to -$2.6 million.

  • Biofrontera's Invested Capital fell 14667.27% to -$2.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.6 million, marking a year-over-year decrease of 14667.27%. This contributed to the annual value of $4.4 million for FY2024, which is 4902.84% down from last year.
  • According to the latest figures from Q3 2025, Biofrontera's Invested Capital is -$2.6 million, which was down 14667.27% from -$4.7 million recorded in Q2 2025.
  • Biofrontera's Invested Capital's 5-year high stood at $30.8 million during Q4 2022, with a 5-year trough of -$17.4 million in Q3 2021.
  • Moreover, its 5-year median value for Invested Capital was $8.5 million (2023), whereas its average is $8.8 million.
  • In the last 5 years, Biofrontera's Invested Capital skyrocketed by 24865.94% in 2022 and then tumbled by 14667.27% in 2025.
  • Quarter analysis of 5 years shows Biofrontera's Invested Capital stood at $14.6 million in 2021, then surged by 111.39% to $30.8 million in 2022, then plummeted by 71.78% to $8.7 million in 2023, then crashed by 49.03% to $4.4 million in 2024, then tumbled by 158.22% to -$2.6 million in 2025.
  • Its last three reported values are -$2.6 million in Q3 2025, -$4.7 million for Q2 2025, and $500000.0 during Q1 2025.